CAMP4 Therapeutics Corpor... (CAMP)
1.91
-0.09 (-4.50%)
At close: Apr 14, 2025, 12:55 PM
-4.50% (1D)
| Bid | 1.86 |
| Market Cap | 38.41M |
| Revenue (ttm) | 264.74M |
| Net Income (ttm) | -101.35M |
| EPS (ttm) | -11.04 |
| PE Ratio (ttm) | -0.17 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 2.46 |
| Volume | 20,027 |
| Avg. Volume (20D) | 39,359 |
| Open | 2.10 |
| Previous Close | 2.00 |
| Day's Range | 1.89 - 2.00 |
| 52-Week Range | 1.89 - 12.30 |
| Beta | -3.35 |
About CAMP
CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA....
Industry Biotechnology
Sector Healthcare
IPO Date Oct 11, 2024
Employees 55
Stock Exchange NASDAQ
Ticker Symbol CAMP
Website https://www.camp4tx.com/
Analyst Forecast
According to 4 analyst ratings, the average rating for CAMP stock is "Buy." The 12-month stock price forecast is $18, which is an increase of 844.88% from the latest price.
Stock Forecasts5 months ago
+13.38%
CAMP4 Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
10 months ago
-62.17%
CalAmp shares are trading lower after the company announced it entered into a restructuring support agreement to take the company private and has voluntarily initiated proceedings under Chapter 11 of the United States Bankruptcy Code.
